The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 10/29/2019 featuring funding details for Nuvation Bio, Cureatr, and much more. This page will be updated throughout the day to reflect any new fundings.
Nuvation Bio — $275M
Nuvation Bio, the biotech startup focused on developing next generation oncology therapies, has raised $275M in funding from investors that include EDBI, Aisling Capital, Omega Funds, Altitude Life Science Ventures, Pavilion Capital, and The Baupost Group. Nuvation Bio was founded by David Hung and Gary Hattersley in 2018.
Cureatr — $427K
Cureatr, the group messaging platform for the healthcare industry., has raised an additional $427K in funding according to a recent SEC filing. The filing lists the total offering at $4M and this close comes from five investors. Founded by Alex Khomenko and Joseph Mayer in 2011, Cureatr had previously raised a total of $19.1M in reported equity funding.
